Document details
 Add to my MEDBOX

WHO Good Governance for Medicines programme. an innovative approach to prevent corruption in the pharmaceutical sector

Baghdadi-Sabeti , G.; and F. Serhan World Health Organization WHO (2010) C_WHO
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
Source:
https://cdn.who.int/media/docs/default-source/health-financing/technical-briefs-background-papers/25ggm.pdf
Topics:
good governance corruption pharmaceutical services